Levetiracetam Teva

Levetiracetam, the active ingredient in Levetiracetam Teva, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. - Partial seizures: helps control focal onset seizures and reduces their frequency. - Generalized tonic‑clonic seizures: provides seizure freedom or reduction in tonic‑clonic episodes. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Fatigue: unusual tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness during the day. - Irritability: mood changes or agitation. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Blood disorders: unexplained bruising or low blood counts. - Severe skin rash: extensive redness or blistering.

Before initiating therapy, consider the following safety measures. - Renal impairment: adjust dose based on kidney function. - Hepatic impairment: monitor liver enzymes and adjust if needed. - Pregnancy: discuss potential risks with a healthcare professional. - Concomitant CNS depressants: use caution as additive sedation may occur. - Abrupt discontinuation: taper gradually to avoid seizure worsening. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: strong enzyme inducer that may lower levetiracetam levels. - Phenytoin: may reduce levetiracetam exposure. - Phenobarbital: can decrease levetiracetam concentration.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam plasma levels. - Fluoroquinolones: potential for enhanced CNS side effects. - Certain antidepressants: monitor for increased sedation. - Alcohol: may potentiate dizziness and somnolence. - Oral contraceptives: efficacy may be reduced; consider alternative contraception.